Xenograft Bone Substitute

Next frontier of bone regeneration

In July 2012 IBI introduced SmartBone® on the EU and international market: an innovative bone substitute produced by combining a bovine mineral bone matrix with bioresorbable polymers and collagen fragments.
SmartBone® is CE marked according to 93/42/EEC Medical Device Directive classified as a class III Medical Device.

Advantages of SmartBone®

Easy dust free shaping with any type of surgical tool (for example: bone cutter, drill); Resistant to heavy loads and to heavy surgical maneuvering;
Far better stability of the augmented bone graft vs the loose granules;
Bigger defects do not need autologous bone, thus reducing patient morbidity;
No resorption: the polymeric coating protects the graft during initial healing/osteointegration period;
Readily absorbs blood.

Dental indications

SmartBone® is intended to be used for reconstruction surgeries and for bone regeneration/augmentation, in the following indications:
Regeneration of periodontal bone defects;
Regeneration of extraction alveoli;
Regeneration of cavities between the alveolar wall and immediate implants;
Horizontal alveolar ridge augmentation;
Sinus lift floor elevation;
Alveolar ridge augmentation at implant sites with sufficient residual bone and a good blood supply.

A Bone graft born from Advanced Tissue Engineering Technology

SmartBone®, SmartBone® ORTHO, SmartBone® On Demand™ and SwissBone® are produced by combining natural mineral bone structures with bioresorbable polymers and collagen fragments.